A phase I dose-escalation study of LY2875358, a bivalent...

Investigational New Drugs 2016 / 10 Vol. 34; Iss. 5

A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies

Yoh, Kiyotaka, Doi, Toshihiko, Ohmatsu, Hironobu, Kojima, Takashi, Takahashi, Hideaki, Zenke, Yoshitaka, Wacheck, Volker, Enatsu, Sotaro, Nakamura, Takashi, Turner, Kellie, Uenaka, Kazunori
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
34
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0370-7
Date:
October, 2016
File:
PDF, 952 KB
english, 2016
Conversion to is in progress
Conversion to is failed